Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
GDOC vs HIAHX
Shared holdings
23
GDOC covered by HIAHX
46.19%
HIAHX covered by GDOC
46.19%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 40 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
GDOC (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 12.20% | |
| JOHNSON&JOHNSON | 8.10% | |
| ASTRAZENECA PLC | 6.41% | |
| MERCK & CO | 5.99% | |
| BOSTON SCIENTIFIC CORP | 5.81% | |
| THERMO FISHER SCIENTIFIC INC | 4.62% | |
| INTUITIVE SURGICAL INC | 4.47% | |
| GUARDANT HEALTH INC | 3.73% | |
| HOYA CORP | 3.63% | |
| ARGENX SE SPONSORED ADR | 3.60% | |
| CENCORA INC | 3.39% | |
| ABBOTT LABS | 3.13% | |
| LONZA GROUP -REG | 2.94% | |
| AGILENT TECHNOLOGIES INC | 2.91% | |
| DEXCOM INC | 2.68% | |
| ROIVANT SCIENCES LTD | 2.23% | |
| METTLER-TOLEDO INTL INC | 1.77% | |
| APOGEE THERAPEUTICS INC | 1.62% | |
| Sartorius Stedim Biotech S.A. | 1.59% | |
| IONIS PHARMACEUTICALS INC | 1.41% | |
| QIAGEN NV | 1.39% | |
| REPLIGEN CORP | 1.26% | |
| INSMED INC | 1.22% | |
| PENUMBRA INC | 1.14% | |
| Goldman Sachs Treasury Obligations Fund Institutional Class | 1.09% | |
| NATERA INC | 1.05% | |
| XENON PHARMACEUTICALS INC | 1.03% | |
| ROYALTY PHARMA PLC | 1.01% | |
| UNITEDHEALTH GRP | 1.01% | |
| CYTOKINETICS INC | 0.98% | |
| BRIDGEBIO PHARMA INC | 0.92% | |
| MADRIGAL PHARMACEUTICALS INC | 0.89% | |
| RHYTHM PHARMACEUTICALS INC | 0.88% | |
| CG ONCOLOGY INC | 0.83% | |
| ARCELLX INC | 0.82% | |
| GENEDX HOLDINGS CORP-A | 0.59% | |
| REVOLUTION MEDICINES INC | 0.52% | |
| INSULET CORP | 0.47% | |
| ULTRAGENYX PHARMA INC | 0.37% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.30% |
HIAHX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 12.07% | |
| MERCK & CO | 6.71% | |
| JOHNSON&JOHNSON | 6.04% | |
| UNITEDHEALTH GRP | 4.11% | |
| INTUITIVE SURGICAL INC | 3.53% | |
| ABBVIE INC | 3.18% | |
| ABBOTT LABS | 2.88% | |
| DANAHER CORP | 2.83% | |
| EDWARDS LIFESCIENCES CORP | 2.73% | |
| VERTEX PHARMACEUTICALS INC | 2.50% | |
| BOSTON SCIENTIFIC CORP | 2.21% | |
| CVS HEALTH CORP | 2.09% | |
| CENCORA INC | 1.97% | |
| REGENERON PHARMACEUTICALS INC | 1.87% | |
| HCA HEALTHCARE INC | 1.86% | |
| THERMO FISHER SCIENTIFIC INC | 1.70% | |
| ELEVANCE HEALTH INC | 1.60% | |
| MEDTRONIC PLC | 1.45% | |
| CARDINAL HEALTH INC | 1.39% | |
| GSK PLC | 1.36% | |
| AGILENT TECHNOLOGIES INC | 1.25% | |
| UNITED THERAPEUTICS CORP DEL | 1.23% | |
| STRYKER CORP | 1.12% | |
| ARGENX SE SPONSORED ADR | 1.07% | |
| UCB SA | 1.05% | |
| DEXCOM INC | 1.01% | |
| BIOGEN INC | 0.96% | |
| APELLIS PHARMACEUTICALS INC | 0.91% | |
| STERIS PLC | 0.85% | |
| IONIS PHARMACEUTICALS INC | 0.81% | |
| INCYTE CORP | 0.79% | |
| ALNYLAM PHARMACEUTICALS INC | 0.78% | |
| MADRIGAL PHARMACEUTICALS INC | 0.77% | |
| Ascendis Pharma A/S | 0.76% | |
| BRISTOL-MYERS SQUIBB CO | 0.74% | |
| ELANCO ANIMAL HEALTH INC | 0.71% | |
| GALDERMA GROUP A | 0.69% | |
| CYTOKINETICS INC | 0.68% | |
| ENCOMPASS HEALTH CORP | 0.64% | |
| PROTAGONIST THERAPEUTICS INC | 0.64% | |
| State Street Navigator Securities Lending Government Money Market Portfolio | 0.62% | |
| REVOLUTION MEDICINES INC | 0.61% | |
| BIO-TECHNE CORP | 0.60% | |
| DISC MEDICINE INC | 0.58% | |
| ALIGNMENT HEALTHCARE INC | 0.58% | |
| PHARVARIS NV | 0.57% | |
| HEARTFLOW INC | 0.57% | |
| OPTION CARE HEALTH INC | 0.52% | |
| SCHOLAR ROCK HOLDING CORP | 0.51% | |
| Icon Public Limited Company | 0.51% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.